- Home
- VOD vs RVMD Comparison
VOD vs RVMD Comparison
Compare VOD & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOD | RVMD |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United Kingdom | United States |
| Employees | 86702 | 883 |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7B | 30.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VOD | RVMD |
|---|---|---|
| Price | $13.14 | $192.33 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 19 |
| Target Price | N/A | ★ $140.84 |
| AVG Volume (30 Days) | ★ 3.6M | 3.0M |
| Earning Date | 06-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.47 | N/A |
| Revenue Next Year | $5.90 | $533.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.66 | $34.00 |
| 52 Week High | $16.61 | $193.10 |
Technical Indicators
Market Signals| Indicator | VOD | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.55 | 73.88 |
| Support Level | $13.15 | $93.39 |
| Resistance Level | $15.81 | N/A |
| Average True Range (ATR) | 0.21 | 7.01 |
| MACD | -0.12 | 2.32 |
| Stochastic Oscillator | 12.25 | 97.15 |
Price Performance
Historical ComparisonAbout VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses across Europe, Africa, and the Middle East. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns two cable networks after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK, Vodafone merged with CK Hutchison in 2024, consolidating the mobile market. It also divested its Spanish and Italian divisions in that same year, given their low returns on invested capital.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.